Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX7VSY
|
||||
Drug Name |
(S)-N-((R)-2-(benzyloxy)-1-cyanoethyl)-4-methyl-2-(2-(4-phenylpiperidin-1-yl)acetamido)pentanamide
|
||||
Synonyms |
CHEMBL380665
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C29H38N4O3
|
||||
Canonical SMILES |
CC(C)C[C@H](NC(=O)CN1CCC(CC1)c2ccccc2)C(=O)N[C@@H](COCc3ccccc3)C#N
|
||||
InChI |
InChI=1S/C29H38N4O3/c1-22(2)17-27(29(35)31-26(18-30)21-36-20-23-9-5-3-6-10-23)32-28(34)19-33-15-13-25(14-16-33)24-11-7-4-8-12-24/h3-12,22,25-27H,13-17,19-21H2,1-2H3,(H,31,35)(H,32,34)/t26-,27+/m1/s1
|
||||
InChIKey |
IVVYCBBKQYBPIG-SXOMAYOGSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin L | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.